Company Filing History:
Years Active: 2019-2020
Title: Byung Pil Lim: Innovator in Vaccine Development
Introduction
Byung Pil Lim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of vaccine development, particularly in the area of viral neutralization. With a total of two patents to his name, Lim's work focuses on enhancing the efficacy of vaccines against influenza and hepatitis B viruses.
Latest Patents
Lim's latest patents include an adjuvant composition containing at least one influenza virus neutralizing and binding molecule. This invention relates to a composition that can increase the effects of a vaccine, thereby enhancing the immune response upon administration. It is particularly useful in preventing diseases caused by viruses. His second patent involves an epitope of the hepatitis B virus surface antigen and a binding molecule that specifically neutralizes the hepatitis B virus. This invention is notable for its ability to avoid escape mutations that can reduce the efficacy of existing vaccines, making it a valuable tool in the prevention and treatment of HBV.
Career Highlights
Byung Pil Lim is currently associated with Celltrion Inc., a leading biopharmaceutical company. His work at Celltrion has allowed him to focus on innovative solutions in vaccine technology. Lim's research has the potential to significantly impact public health by providing more effective vaccines.
Collaborations
Some of Lim's notable coworkers include Shin Jae Chang and Soo Young Lee. Their collaborative efforts contribute to the advancement of vaccine research and development.
Conclusion
Byung Pil Lim is a key figure in the field of vaccine innovation, with patents that address critical challenges in viral neutralization. His contributions are poised to enhance the effectiveness of vaccines and improve health outcomes globally.